EUVIMEDEUVIMED entdecken
Open Access

Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise.

Marika Pane, Enrico S Bertini, Eleonora Russo, Francesca Gatto, Roberto Di Virgilio, Federico Spandonaro, Daniela d'Angela, Barbara Polistena, Margherita d'Errico

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · 01.09.2024 · 43 (3) · 95-101

DOI: 10.36185/2532-1900-487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, erschienen am 01.09.2024. Verfasst von Marika Pane und 8 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Neurology, Catholic University, Rome, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Genetic Therapy. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Duchenne muscular dystrophy (DMD) is a heritable disorder that causes a rapid and progressive loss of ambulatory skills. There is no curative therapy for this pathology, that is currently managed with a combination of physiotherapy and pharmacological interventions limiting the progression of the disease (e.g. corticosteroids, cardiac medications). However, a new opportunity is represented by gene therapy, a promising treatment that, however, requires significant expertise during the whole delivery of care and a solid organisational infrastructure. An organisational strategy that could effectively support its delivery to DMD patients in Italy is the hub-and-spoke model. However, an accurate portrait of the present network of DMD centres of expertise in Italy and of their readiness in the delivery of gene therapy is paramount, to facilitate access to this experimental medicine in the future.

Methods

In this context, the present study aimed to map the DMD centres of expertise in Italy and later evaluate their preparedness in terms of gene therapy delivery. For this purpose, a series of items was proposed to 30 centres in Italy, of which 20 responded.

Results

After assessing the readiness of the involved centres in terms of patient preparation, therapy infusion, close surveillance, and long-term follow-up, we proposed a suitable organizational model, namely a flexible hub-and-spoke model, for the delivery of gene therapy in the Italian DMD network and solutions to tackle the challenges emerged from the survey.

Conclusion

Overall, the present study detected an adequate readiness of the Italian DMD centres of expertise, despite observing a significant room for improvement in digital infrastructures, culture, and training.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneGenetic TherapyHumansItaly

Stichwörter der Autor:innen

Duchenne muscular dystrophydelivery of caregene therapyhealthcare managementhub-and-spokelean management

Autor:innen und Institutionen

  • Paediatric Neurology, Catholic University, Rome, Italy.
  • Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Unit of Neuromuscular and Neurodegenerative Disorders, Dep.t of Neurosciences, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Pfizer Italia Medical Affairs Director - Rare Disease, Italy.
  • Pfizer Italia Medical Affairs Scientist - Rare Disease, Italy.
  • Pfizer Italia - HTA HEOR Lead, Italy.

Zitieren

APA

Pane, M., Bertini, E. S., Russo, E., Gatto, F., Di Virgilio, R., Spandonaro, F., d'Angela, D., Polistena, B., & d'Errico, M. (2024). Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, 43(3), 95-101. https://doi.org/10.36185/2532-1900-487

Vancouver

Pane M, Bertini ES, Russo E, Gatto F, Di Virgilio R, Spandonaro F, et al. Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases. 2024;43(3):95-101. doi:10.36185/2532-1900-487

BibTeX
@article{Pane2024,
  author = {Pane, Marika and Bertini, Enrico S and Russo, Eleonora and Gatto, Francesca and Di Virgilio, Roberto and Spandonaro, Federico and d'Angela, Daniela and Polistena, Barbara and d'Errico, Margherita},
  title = {Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise},
  journal = {Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases},
  year = {2024},
  volume = {43},
  number = {3},
  pages = {95--101},
  doi = {10.36185/2532-1900-487}
}
Kostenlos starten →